Precision Biosciences (DTIL) Environmental, Social & Governance (ESG) Data

Company Profile

Search within these filings

View filings

Exhibits within filings

Filing insights

Export filings list

Export a CSV file of filings or unique filing companies (up to first 5,000 results).

Download list of filings Download list of companies

Employees

Data from SEC filings

Employee count

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Agriculture Air Circular Emission Environment Environmental Forest Intensity Life Cycle Materials Natural Resources Nature Offset Package Packaging Pandemic Raw Materials Regenerative Waste Water Wind Access African American Asian Benefits Black California Consumer Privacy Act Collective Bargaining Community Culture Customer Cyber Cybersecurity Data Privacy Data Security Death Demographic Disability Diversity Diversity and Inclusion Employee Employee Resource Group Engagement Ethnic Ethnicity Gender General Data Protection Regulation Health and Safety Health Care Healthcare Hire Hiring Human Capital Human Resources Incident Injured Injuries Injury Latinx LGBTQ Minority Perquisites Privacy Recall Recruit Recruitment Reimbursement Retention Retirement Safety Satisfaction Skill Skilled Skills Social Society Stakeholder Supplier Supply Chain Talent Training Union Women Workers Workforce Action Plan Anti-corruption Assessment Assurance Audit Board Evaluation Bonus Bribery Chronic Class Action Lawsuit Classified Classified Board Commitment Conflict of Interest Corporate Governance Corporate Purpose Corruption Department of Enterprise Risk Management Ethics Executive Compensation Expert Fraud Goals Governance Hedging Incentive Incentivize Independence Independent Independent Chair Innovation Innovative Investigation Key Performance Indicator Lawsuit Lead Independent Director Leadership Litigation Long-term Majority Mission Oversee Oversight Perquisite Purpose R&D Reputation Reputational Research and Development Responsibility Responsible Self-evaluation Special Meeting Strategy Sustainability Sustainable Targets Tax Tax Gross Up Tenure Term Limit Transparency Voting Rights

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On May 10, 2022, Precision BioSciences, Inc. (the “Company”) held its annual meeting of stockholders (the “Meeting”). A total of 46,596,353 shares of the Company’s common stock, par value $0.000005 (the “Common Stock”) were present in person or represented by proxy at the Meeting, representing approximately 76.34% of the Common Stock outstanding as of the March 15, 2022 record date. Following are the voting results for the proposals considered and voted upon at the Meeting, each of which were described in the Company’s Definitive Proxy Statement filed with the Securities and Exchange Commission on March 29, 2022.